Andrew Mok
Stock Analyst at Barclays
(2.44)
# 2,422
Out of 4,761 analysts
148
Total ratings
46.67%
Success rate
-0.48%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYH Community Health Systems | Maintains: Equal-Weight | $5 → $4 | $3.54 | +12.99% | 5 | Feb 20, 2025 | |
| DVA DaVita | Maintains: Equal-Weight | $164 → $169 | $145.92 | +15.82% | 10 | Feb 18, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $255 → $270 | $271.30 | -0.48% | 7 | Feb 13, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $161 | $137.24 | +17.31% | 11 | Feb 13, 2025 | |
| CVS CVS Health | Maintains: Overweight | $71 → $73 | $65.09 | +12.15% | 7 | Feb 13, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $372 → $339 | $291.46 | +16.31% | 4 | Feb 7, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $116 → $118 | $99.89 | +18.13% | 14 | Feb 7, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $420 → $339 | $299.68 | +13.12% | 4 | Jan 31, 2025 | |
| HCA HCA Healthcare | Maintains: Overweight | $392 → $366 | $321.50 | +13.84% | 9 | Jan 27, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $501 → $512 | $390.50 | +31.11% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $74 | $62.67 | +18.08% | 6 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $655 → $642 | $502.42 | +27.78% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $91 → $93 | $58.48 | +59.03% | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $43 | $40.67 | +5.73% | 11 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $2 | $3.62 | -44.75% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $19 → $21 | $24.64 | -14.77% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7 → $8 | $14.37 | -44.33% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $256 → $271 | $184.17 | +47.15% | 20 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $112.07 | -25.94% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $35 | $25.67 | +36.35% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $8.44 | +42.18% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $91.09 | +4.29% | 7 | Aug 2, 2022 |
Community Health Systems
Feb 20, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $3.54
Upside: +12.99%
DaVita
Feb 18, 2025
Maintains: Equal-Weight
Price Target: $164 → $169
Current: $145.92
Upside: +15.82%
Humana
Feb 13, 2025
Maintains: Equal-Weight
Price Target: $255 → $270
Current: $271.30
Upside: -0.48%
Tenet Healthcare
Feb 13, 2025
Maintains: Overweight
Price Target: $190 → $161
Current: $137.24
Upside: +17.31%
CVS Health
Feb 13, 2025
Maintains: Overweight
Price Target: $71 → $73
Current: $65.09
Upside: +12.15%
Molina Healthcare
Feb 7, 2025
Maintains: Equal-Weight
Price Target: $372 → $339
Current: $291.46
Upside: +16.31%
Encompass Health
Feb 7, 2025
Maintains: Overweight
Price Target: $116 → $118
Current: $99.89
Upside: +18.13%
The Cigna Group
Jan 31, 2025
Maintains: Overweight
Price Target: $420 → $339
Current: $299.68
Upside: +13.12%
HCA Healthcare
Jan 27, 2025
Maintains: Overweight
Price Target: $392 → $366
Current: $321.50
Upside: +13.84%
Elevance Health
Jan 24, 2025
Maintains: Overweight
Price Target: $501 → $512
Current: $390.50
Upside: +31.11%
Jan 22, 2025
Maintains: Overweight
Price Target: $85 → $74
Current: $62.67
Upside: +18.08%
Jan 17, 2025
Maintains: Overweight
Price Target: $655 → $642
Current: $502.42
Upside: +27.78%
Dec 13, 2024
Maintains: Overweight
Price Target: $91 → $93
Current: $58.48
Upside: +59.03%
Nov 22, 2024
Maintains: Overweight
Price Target: $76 → $43
Current: $40.67
Upside: +5.73%
Nov 11, 2024
Maintains: Underweight
Price Target: $5 → $2
Current: $3.62
Upside: -44.75%
Nov 8, 2024
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $24.64
Upside: -14.77%
Oct 30, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $14.37
Upside: -44.33%
Oct 25, 2024
Maintains: Overweight
Price Target: $256 → $271
Current: $184.17
Upside: +47.15%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $112.07
Upside: -25.94%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $35
Current: $25.67
Upside: +36.35%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $8.44
Upside: +42.18%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $91.09
Upside: +4.29%